Express Scripts, others denied injunction over US FTC in-house insulin suit
MLex Summary: Express Scripts and other pharmacy benefit managers were denied a preliminarily injunction pending appeal against an administrative proceeding initiated by the US Federal Trade Commission over insulin prices.See attached...To view the full article, register now.
Already a subscriber? Click here to view full article